Embecta Gears Up for Q2 2026 Earnings as Insulin Delivery Leader Faces Market Pressures
Embecta Corp. (EMBC) schedules May 5, 2026 earnings call to discuss Q2 2026 results and operational updates amid competitive insulin delivery market pressures.
EMBCconference callinvestor relations